|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:420-428
© 2000 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Divisions of Thoracic Surgerya and Breast Surgery,c Department of Surgery, and the Biostatistics Service, Department of Epidemiology and Biostatistics,b Memorial Sloan-Kettering Cancer Center, New York, NY.
*Ms F. Ida Hsu is a medical student at the College of Physicians and Surgeons, Columbia University, and her work was supported by a Research Fellowship from Cornell University Medical College.
Address for reprints: Robert J. Downey, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (E-mail: downeyr{at}mskcc.org ).
Objective: The effectiveness of chest wall resection for locally recurrent breast cancer as cancer treatment remains poorly defined, possibly because of the general impression that locally recurrent disease is a harbinger of rapidly progressive metastatic disease and that extensive surgical treatment in these patients is inappropriate. Reports to date have focused on technical feasibility, not long-term outcome.
Methods: We reviewed our experience with 38 women who underwent chest wall resection for locally recurrent breast cancer between October 1987 and May 1997. Overall survival was calculated by the Kaplan-Meier method and the significance of prognostic variables evaluated by log-rank and Cox regression analyses.
Results: The operative mortality rate was 0%. Overall survival at 1, 3, and 5 years after chest wall resection was 74%, 41%, and 18%, respectively, and the proportion of patients free of local recurrence at 1, 3, and 5 years was 59%, 42%, and 13%, respectively. Regional nodal disease and size of largest tumor nodule (>4 cm) were significant predictors of local re-recurrence (P < .01, P = .04); lymph node metastasis was the only predictor of long-term survival (P < .01). Patients with and without synchronous sites of metastatic disease had near-identical 3-year survivals.
Conclusions: Chest wall resection for locally recurrent breast cancer has a low mortality. However, a significant number of patients have the development of local re-recurrence or metastases, and 5-year survival is limited. It is unlikely that complete resection of all locally recurrent disease improves survival. Future studies should focus on the quality of palliation achieved.
This article has been cited by other articles:
![]() |
G. Friedel, T. Kuipers, J. Dippon, F. Al-Kammash, T. Walles, T. Kyriss, S. Veit, M. Greulich, and V. Steger Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer Ann. Thorac. Surg., June 1, 2008; 85(6): 1894 - 1900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Watanabe, T. Watanabe, T. Obama, H. Ohsawa, T. Mawatari, Y. Ichimiya, N. Takahashi, and T. Abe New material for reconstruction of the anterior chest wall, including the sternum J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1212 - 1214. [Full Text] [PDF] |
||||
![]() |
W. Raffoul, M. Dusmet, M. Landry, and H.-B. Ris A novel technique for the reconstruction of infected full-thickness chest wall defects Ann. Thorac. Surg., November 1, 2001; 72(5): 1720 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Warzelhan, E. Stoelben, A. Imdahl, and J. Hasse Results in surgery for primary and metastatic chest wall tumors Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 584 - 588. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |